UPDATE 1-Xenon Pharmaceuticals' acne drug fails mid-stage study
March 24, 2017 at 07:17 AM EDT
March 24 (Reuters) - Xenon Pharmaceuticals Inc said on Friday it would abandon its acne drug, after it failed to meet the main goal in a mid-stage study.